This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Antibioticos. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Sara Olmo: Innovator in Pergolide Synthesis
Introduction
Sara Olmo is a notable inventor based in Turin, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative processes in drug synthesis. Her work has led to advancements in the production of pergolide, a medication used in the treatment of Parkinson's disease.
Latest Patents
Sara Olmo holds a patent for a process for the synthesis of pergolide. This process involves the synthesis of pergolide (Formula (I)) from acid 9,10-dihydrolysergic. The method is designed to be efficient, allowing for the synthesis to be carried out without isolating most intermediates. This approach is particularly advantageous from both yield and safety perspectives. The pergolide produced through this method is of high purity and can be conveniently transformed into pergolide mesylate.
Career Highlights
Throughout her career, Sara has worked with prominent companies in the pharmaceutical industry, including Antibioticos and Uniderm Farmaceutici S.r.l. Her experience in these organizations has contributed to her expertise in drug synthesis and development.
Collaborations
Sara has collaborated with esteemed colleagues such as Walter Cabri and Paolo Paissoni. These partnerships have further enriched her research and innovation in the field.
Conclusion
Sara Olmo is a pioneering inventor whose work in the synthesis of pergolide has made a significant impact in the pharmaceutical industry. Her innovative processes and collaborations highlight her contributions to advancing medical treatments.